Hagiwara H, Takano T, Ogata H, Tsubouchi K, Ichiki K, Takata S, Ishii H, Kitasato Y, Zaizen Y, Yatera K, Kawasaki M, Fujita M, Yoshida M, Maeyama T, Mashimoto A, Furuyama K, Torii R, Suzuki K, Mizuta Y, Tobino K, Harada E, Kiyomi F, Yabuuchi H, Nakanishi Y, Okamoto I

Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias.

BMC Pulm Med 25(1): 468, 2025Pubmed

Yanagihara T, Hata K, Matsubara K, Kunimura K, Suzuki K, Tsubouchi K, Ikegame S, Fukui Y, Okamoto I

Immunophenotyping of T Cells in Lung Malignancies and Cryptogenic Organizing Pneumonia.

J Clin Med 14(2): 316, 2025Pubmed

Koike A, Tsubouchi K, Nakamura S, Takano T, Hashisako M, Hino T, Yabuuchi H, Okamoto I

Diagnostic yield and safety of transbronchial lung cryobiopsy using 1.7-mm probes in interstitial lung disease.

J Thorac Dis 17(6): 3962-3970, 2025Pubmed

Ando H, Tsubouchi K, Yanagihara T, Hata K, Eto D, Suzuki K, Hamada N, Okamoto I

Involvement of naïve T cells in the pathogenesis of osimertinib-induced pneumonitis.

Sci Rep 15(1): 10545, 2025Pubmed

Hamada N, Tokunaga S, Yanagihara T, Tsubouchi K, Ichiki K, Takata S, Ishii H, Kitasato Y, Okamoto M, Yatera K, Kawasaki M, Yoshida M, Maeyama T, Fujita M, Mashimoto A, Furuyama K, Torii R, Suzuki K, Mizuta Y, Tobino K, Harada E, Yabuuchi H, Okamoto I, Nakanishi Y

Diagnostic utility of high-mobility group box 1 for acute exacerbations of idiopathic pulmonary fibrosis.

Sci Rep 15(1): 38705, 2025Pubmed

Takano T, Tsubouchi K, Hamada N, Ichiki K, Torii R, Takata S, Kawakami S, Nakagaki N, Yoshida M, Kitasato Y, Tobino K, Harada E, Ishii H, Wataya H, Maeyama T, Fujita M, Yatera K, Okamoto M, Yabuuchi H, Kiyomi F, Tokunaga S, Nakanishi Y, Okamoto I

Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.

BMC Pulm Med 24(1): 556, 2024Pubmed

Yanagihara T, Hata K, Matsubara K, Kunimura K, Suzuki K, Tsubouchi K, Ikegame S, Baba Y, Fukui Y, Okamoto I

Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis.

Elife 12: RP87288, 2024Pubmed

Hata K, Tsubouchi K, Suzuki K, Eto D, Ando H, Yanagihara T, Kan-O K, Okamoto I

Surfactant protein D prevents mucin overproduction in airway goblet cells via SIRPα.

Sci Rep 14(1): 1799, 2024Pubmed

Nakamura S, Takano T, Nakatsuru K, Tsubouchi K, Yamauchi T, Hashisako M, Iwasaki T, Okamoto I

Interstitial Pneumonia Associated with Nodal T-follicular Helper Cell Lymphoma.

Intern Med 63(23): 3227-3231, 2024Pubmed

Nakahara S, Ishii Y, Egashira R, Tsubouchi K, Kohno M, Takenaka T, Tanaka K, Okamoto I

Lemborexant-induced interstitial lung disease: A case report.

Respirol Case Rep 12(5): e01334, 2024Pubmed

Yanagihara T, Tsubouchi K, Zhou Q, Chong M, Otsubo K, Isshiki T, Schupp JC, Sato S, Scallan C, Upagupta C, Revill S, Ayoub A, Chong SG, Dvorkin-Gheva A, Kaminski N, Tikkanen J, Keshavjee S, Paré G, Guignabert C, Ask K, Kolb MRJ

Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.

Am J Respir Crit Care Med 207(11): 1498-1514, 2023Pubmed

Yanagihara T, Zhou Q, Tsubouchi K, Revill S, Ayoub A, Gholiof M, Chong SG, Dvorkin-Gheva A, Ask K, Shi W, Kolb MR

Intrinsic BMP inhibitor Gremlin regulates alveolar epithelial type II cell proliferation and differentiation.

Biochem Biophys Res Commun 656: 53-62, 2023Pubmed

Tsubouchi K, Hamada N, Tokunaga S, Ichiki K, Takata S, Ishii H, Kitasato Y, Okamoto M, Kawakami S, Yatera K, Kawasaki M, Fujita M, Yoshida M, Maeyama T, Harada T, Wataya H, Torii R, Komori M, Mizuta Y, Tobino K, Harada E, Yabuuchi H, Nakanishi Y, Okamoto I

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.

BMJ Open Respir Res 10(1): e001864, 2023Pubmed

Hata K, Yanagihara T, Matsubara K, Kunimura K, Suzuki K, Tsubouchi K, Eto D, Ando H, Uehara M, Ikegame S, Baba Y, Fukui Y, Okamoto I

Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases.

Front Immunol 14: 1145814, 2023Pubmed

Yanagihara T, Hata K, Matsubara K, Kunimura K, Suzuki K, Tsubouchi K, Ikegame S, Baba Y, Fukui Y, Okamoto I

Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung.

Ann Hematol 102(10): 2959-61, 2023Pubmed

Yanagihara T, Hata K, Suzuki K, Matsubara K, Kunimura K, Tsubouchi K, Eto D, Ando H, Uehara M, Ikegame S, Fukui Y, Okamoto I

Expansion of ST2-expressing macrophages in a patient with bronchiolitis obliterans syndrome.

ERJ Open Res 9(3): 00033-2023, 2023Pubmed

Hata K, Yanagihara T, Matsubara K, Kunimura K, Eto D, Suzuki K, Tsubouchi K, Ikegame S, Fukui Y, Okamoto I

Altered macrophage phenotypes in a case of autoimmune pulmonary alveolar proteinosis.

ERJ Open Res 9(5): 00500-2023, 2023Pubmed

Nakatsuru K, Tsubouchi K, Hirahata M, Nakashima T, Takahata Y, Okamatsu Y, Shiraishi Y, Okamoto I, Harada T

Acute myeloid leukemia and myelodysplastic syndrome associated with a combination of immune checkpoint inhibitor and platinum-based chemotherapy.

Thorac Cancer 14(22): 2225-8, 2023Pubmed